| 1. |
- Assessment of substances
- Managing substances
|
- The use of the precautionary principle in assessment and management of substances
|
| 2. |
- Measuring success
|
- Meeting the goals of CEPA
- State of the environment reporting, monitoring for outcomes
|
| 3. |
- International activities
- Assessment of substances
|
- Are there lessons to be learned from other jurisdictions?
- Should CEPA recognize international decisions?
|
| 4. |
- Assessment of substances
- Managing substances
|
- Improving timelines for assessments and implementation of management tools
|
| 5. |
- Assessment of substances
- Managing substances
|
- Defining and implementing Virtual Elimination (including “level of quantification”)
|
| 6. |
- Assessment of substances
|
- Taking into account vulnerable populations and ecosystems
|
| 7. |
- Assessment of substances
|
- Assessing substances with different inherent toxicities, use of “toxic”
- Regulations for Food and Drug Act substances (in-commerce list, see also meeting 10 — legislative clarity)
- What to do with the Domestic Substance List screening results
|
| 8. |
- Assessment of substances
|
- What information requirements are necessary?
- How much information should be publicly disclosed?
- Should industry or government bare the burden of proof?
|
| 9. |
- Managing substances
|
- How can the Act be better enforced?
- Should the public participation aspects (civil suits) be changed?
- What are the most appropriate tools to apply (regulation, guidelines, pollution prevention plans etc.)
|
| 10./11. |
- Cooperation with the provinces, territories and aboriginal peoples
|
- Aboriginal points of view
- National Advisory Committee
- Equivalency Agreements
- Canadian Council of Ministers of the Environment
|
| 12. |
- Interdepartmental cooperation and legislative overlap
|
- Are there clearly defined roles for departments?
- Is there legislative clarity?
|
| |
|
|
| |
|
|
| |
|
|